The pill that prevents HIV is free. Why do so few people know about it?
Translated from Greek and summarized by DistantNews. Read the original for the full story.
At a glance
Explainer
Named sources
Context piece
- HIV-prevention treatment PrEP is available free through Greece’s public health system, but only an estimated 1,000 to 1,500 people use it.
- Infectious disease specialist Eleni Kakalou discusses how PrEP works, who can benefit, and why awareness and uptake remain limited.
The HIV-prevention pill PrEP is available free through Greece’s public health system, yet only an estimated 1,000 to 1,500 people are taking it.
Eleni Kakalou, an infectious disease specialist responsible for the PrEP clinic at Sotiria Hospital, explains how the treatment works and which people can benefit from it.
The article examines why PrEP continues to reach far fewer people than those who need it, despite now being offered through the national health system.
About this summary
Originally published by Kathimerini in Greek. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.
More Stories
From Our Blog
News in Translation: What Gets Lost, and How We Keep the Framing
Diaspora Media: How Communities Follow News From Home
Traveling Where the Press Is Not Free: How to Read the News There
The Digital Nomad's Guide to Local News
The Same Story, Different Countries: How Coverage Changes at the Border
